上海劲马实验设备有限公司作者
劲马产品文献:小鼠白介素1β (IL-1β)、(TNF-α)ELISA试剂盒引用文献
资料类型 | pdf文件 | 资料大小 | 1879765 |
下载次数 | 0 | 资料图片 | 【点击查看】 |
上 传 人 | 上海劲马实验设备有限公司 | 需要积分 | 0 |
关 键 词 | 劲马产品文献:小鼠白介素1β (IL-1β)、(TNF-α)ELISA试剂盒引用文献 |
- 【资料简介】
【文献标题】Crocetin Downregulates the Proinflammatory Cytokines in Methylcholanthrene-Induced Rodent Tumor Model and Inhibits COX-2 Expression in Cervical Cancer Cells
【作者】Bing Chen, Zhao-Hui Hou, Zhe Dong,et.al
【作者单位】Air Force General Hospital(空军总医院)
【文献中引用产品】
小鼠白介素1β (IL-1β)ELISA试剂盒
小鼠肿瘤坏死因子α(TNF-α)ELISA试剂盒
【关键词】
【DOI】doi.org/10.1155/2015/829513
【影响因子(IF)】3.24
【出版期刊】《Biomed Research International》
【产品原文引用】
Measurement of IL-1β and TNF-α Level. The concentration of IL-1β and TNF-α was determined using a commercial ELISA kit (Shanghai Jinma Biological Technology, Inc.,China) following the manufacturer’s instruction.
Assessment of iNOS Protein Histochemistry. The tumors were dissected free from soft tissues at the end of the study and collected on chrome gel subbed slides. Tissue sections were fixed in 50% acetone in phosphate-buffered saline for 3 minutes at room temperature and endogenous peroxidase activity was blocked by 1.5% H2O2 in methanol for 15 minutes. The iNOS protein was determined using a commercial ELISA kit (Shanghai Jinma Biological Technology, Inc.,China) following the manufacturer’s instruction.
Crocetin Inhibited COX-2 Production in HeLa Cells. Analysis of COX-2 production was performed using an ELISA kit according to manufacturer’s instructions (Shanghai Jinma Biological Technology, Inc., China). HeLa cells were treated with various concentrations of crocetin (1, 10, 50, and100 mol/L) for 24 h. Cell culture supernatants were collected to measure the concentration of COX-2. Production of COX-2 was normalized to protein concentrations.
完整版PDF文献请咨询在线客服或者联系我司业务员!
更多公司福利请关注“上海劲马”微信公众号!
- 凡本网注明"来源:环保在线"的所有作品,版权均属于环保在线,转载请必须注明环保在线,https://www.hbzhan.com。违反者本网将追究相关法律责任。
- 企业发布的公司新闻、技术文章、资料下载等内容,如涉及侵权、违规遭投诉的,一律由发布企业自行承担责任,本网有权删除内容并追溯责任。
- 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
- 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。